200,000+ products from a single source!

sales@angenechem.com

Home > Intramolecular Aminoboration of Unfunctionalized Olefins

Intramolecular Aminoboration of Unfunctionalized Olefins


Chun-Hua Yang, Yu-Shi Zhang, Wen-Wen Fan, Gong-Qing Liu, and Yue-Ming Li

 

 

Organoboron compounds have found widespread application in a variety of carbon–carbon and carbon–heteroatom coupling reactions. Furthermore, boronic acid moieties have emerged as important functional groups in biologically active compounds. For example, an a-aminoboronic acid is a key structure in the proteasome inhibitor Velcade (bortezomib), and b-aminoboronic acids have been used as a key subunit in peptidomimetics with antitubercular activity.
 

Traditionally, organoboron compounds have been prepared by transmetalation reactions between organometallic compounds, such as organolithium and organomagnesium reagents, and borates, by the hydroboration of alkenes and alkynes, by the haloboration or aminoboration of alkynes, by the borylation of C=X double bonds, by the borylation of C¢H/C¢X bonds, and by other miscellaneous methods.


Recently, Hirano, Miura, and co-workers[10] and Tortosa and co-workers[11] described the copper(I)-catalyzed simultaneous addition of nitrogen and boron atoms to C¢C multiple bonds or their equivalents for the preparation of aminoboron compounds. In the presence of a catalytic amount of CuCl, the intermolecular aminoboration of olefins with bis(pinacolato)diboron and O-benzoyl N,N-dialkyl hydroxylamines produced the corresponding b-aminoboron compounds in good to excellent yields (Scheme 1 a). We are interested in developing new, straightforward procedures for the amino-boration of C¢C multiple bonds. Herein, we report our recent results on the direct and catalyst-free intramolecular aminoboration of unfunctionalized C=C double bonds (Scheme 1 b).


In the course of searching for new methods for the amination of C¢C multiple bonds, we found that the intramolecular fluoroamination of unfunctionalized olefins was possible with BF3 as the fluorine source and PhI(OAc)2 as the reaction promoter.[12] We assumed that the direct aminoboration of C=C double bonds should be possible if an N¢B intermediate could be generated during the reaction. In this context, an aminoboration reaction was proposed with BF3·Et2O as the boron source. However, no desired aminoboration product was detected when 1 a was treated with BF3·Et2O. Instead, a very slow intramolecular hydroamination reaction occurred, which was complete after 24 h at 60 8C (Scheme 2).


We reasoned that BF3 would interact with the sulfonamide substrate 1 a to form a Lewis pair with either the nitrogen or oxygen atom of the sulfonamido group. The formation of an N¢BF2 bond is difficult owing to the high dissociation energy of B¢F bonds. Instead, Lewis acid mediated reactions took place, and the hydroamination product was isolated. Given that the dissociation energy of a B¢Cl bond is lower than that of a B¢F bond, we reasoned that different reactions should take place if BCl3 was used instead of BF3 under similar reaction conditions. To test this assumption, we added a stoichiometric amount of BCl3 to a solution of 1 a. After 12 h at room temperature, the desired aminoboration product 2 a was obtained (Scheme 3). The structure of 2 a was confirmed by X-ray diffraction.


Encouraged by this result, we optimized the conditions for this direct intramolecular aminoboration reaction. Preliminary results indicated that the reaction medium was crucial for the reaction. Haloalkane solvents were generally suitable, and 1,2-dichloroethane (DCE) gave the most promising result. This solvent was then used as the reaction medium for further studies. Polar aprotic solvents, such as THF, 1,4-
dioxane, DMF, and acetonitrile, were not suitable for the reaction, possibly as a result of their strong interaction with BCl3 and subsequent deactivation of the latter. When the reaction was carried out in toluene, the expected aminoboration product was also obtained. However, the removal of toluene was difficult as compared to the removal of DCE, and reaction in toluene was not pursued further. No significant rate difference was observed when the reaction was carried out at 30 8C instead of 25 8C. Therefore, subsequent reactions were carried out at room temperature without special control of the reaction temperature. A reaction with BBr3 as the boron source gave a similar result. Studies with BBr3 were not continued owing to the relatively difficult conditions needed to handle the reagent.

 

Having established optimal reaction conditions, we also studied the effect of the protecting group on the course of the reaction. We found that the basicity and nucleophilicity of the nitrogen atom were crucial factors. When the amino group was protected with a tosyl group, the aminoboration product was obtained in good yield. Other protecting groups, such as benzyl, acetyl, trifluoroacetyl, and tert-butoxycarbonyl (Boc) groups, were not suitable, and no aminoboration product was detected when substrates bearing these protecting groups were subjected to the reaction. Deprotection occurred with
the isolation of the corresponding primary amine when a Bocprotected substrate was used. These results indicated that for the aminoboration to proceed, the amino/amido group must have balanced basicity/nucleophilicity. Strongly nucleophilic amino/amido groups will interact more strongly with BCl3, thus leading to the deactivation of both the nitrogen and the boron atom.

 

As the purification of boronic acids on a silica-gel column is sometimes problematic, the obtained boronic acids were converted into the corresponding boronates[14] to facilitate product purification. A variety of N-(4-pentenyl)sulfonamide substrates 1 were subjected to the intramolecular aminoboration reaction. After complete consumption of the starting material, the reaction mixture was carefully treated with water, and the crude product was separated from the mixture and treated with pinacol and magnesium sulfate to give the corresponding pinocol boronate. Reactions of p-toluene-, methane-, 2-nitrobenzene-, and 4-nitrobenzenesulfonamide substrates all proceeded readily, and the corresponding boronates were isolated in good overall yields (Table 1).

 

The reaction was not affected significantly by the Thorpe–Ingold effect (compare the formation of products 3 a, 3 f, 3 h, and 3 k).[15] Substrates with substituents on the main chain, such as 2,2-diphenyl (substrate 1 a), ¢(CH2)5¢ (substrate 1 f), or 2,2-dimethyl (substrate 1 h), were transformed efficiently into the desired aminoboration products, and the aminoboration of substrates without substituents on the main chain (substrates 1 k–m) also gave the corresponding aminoboration products in satisfactory yields (Table 1, entries 11–13).

 

Substrate 1 e did not undergo the aminoboration reaction. Instead, the Friedel–Crafts alkylation product 3 e was isolated in high yield (Table 1, entry 5).[13] A gram-scale synthesis of 2 a was also carried out to test the scalability of the method: The aminoboration of 1 a on a 5.0 mmol scale afforded boronic acid 2 a in 83% yield. Furthermore, functional-group transformations by oxidation, amination, and Suzuki coupling reactions were possible.


We next turned our attention to the intramolecular aminoboration of N-(5-hexenyl)sulfonamide substrates. Reactions of N-(5-hexenyl)sulfonamide substrates 4 generally proceeded less efficiently than those of N-(4-pentenyl)sulfonamide substrates 1, possibly as a result of the disfavored entropic nature of the cyclization reactions.  However, aminoboration products 5 were still isolated in moderate to
good yields under the optimized conditions (Table 2).

 

Following the synthesis of [(4,4-diphenyl-1-tosylpyrrolidin-2-yl)methyl]boronic acid (2 a), 2-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-ylmethyl)pyrrolidines (3), and 2-(4,4,5,5tetramethyl[1,3,2]dioxaborolan-2-ylmethyl)piperidines (5), we also investigated the synthesis of different 2-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-ylmethyl)-2,3-dihydro-1H-indoles 7 by this method. The desired aminoboration products 7 a–f were isolated in moderate overall yields, and the reaction was not overly sensitive to the electronic effect of substituents on the benzene ring (Table 3).

 

The formation of the Friedel–Crafts alkylation product 3 e rather than the corresponding aminoboration product when the trisubstituted substrate 1 e was subjected to the reaction (Table 1) indicated the formation of a carbenium cation intermediate. The carbenium cation could be formed by protonation of the substituted C=C double bond with HCl when the corresponding carbenium cation intermediate
showed enough stability. Reactions of terminal alkenes could proceed through the aminoboration pathway since the formation of the corresponding secondary carbenium cation would be slow and less favored.

 

We carried out control experiments to study the possible formation of HCl during the aminoboration reaction. Two reactions were examined under the standard aminoboration conditions, and sodium carbonate was added to one of the two reaction mixtures. The reactions were carried out in an ice–water bath and were sampled every 10 min. The study showed that reactions in the presence of Na2CO3 proceeded slightly faster than reactions without the base (Table 4). This result possibly supports the assumption of the formation of HCl during the reaction. Removal of HCl from the reaction system should help to move the equilibrium to the N¢BCl2 side and speed up the reaction.

 

NMR spectroscopic experiments were also carried out to study the interaction between BCl3 and the sulfonamide functional group. As a direct NMR spectroscopic study on the interaction between the substrate and BCl3 was difficult owing to the fast conversion of the starting material into the aminoboration product, N-methyl-p-toluenesulfonamide (TsNHMe) was used as a model substrate. 1H NMR spectra showed that the sulfonamide signals changed significantly after the addition of BCl3. Similarly, the 11B NMR signal of BCl3 changed significantly after the addition of TsNHMe. We reasoned that this change was due to the strong interaction between BCl3 and the sulfonamide. DFT calculations were also carried out. Preliminary results indicated that the departure of HCl from the Lewis adduct was the rate-limiting step. However, this step was energetically favored both kinetically and thermodynamically. The intramolecular aminoboration step was found to be a fast step with a low energy
barrier.

 

On the basis of previously reported results and these preliminary studies, we propose a possible reaction pathway for the intramolecular aminoboration reaction in Scheme 4: When BCl3 is mixed with the substrate, it interacts with the sulfonamide nitrogen atom to form an LA···NHRTs adduct A. The elimination of HCl from A to give an N¢BCl2 intermediate B is the rate-limiting step. It is also a fast step, and the addition of a base had little effect on the course of the reaction. A downfield shift of the 1H NMR signals for the methylene hydrogen atoms adjacent to the nitrogen atom was observed owing to the attachment of an electron-withdrawing boron group to the nitrogen atom. Intramolecular aminoboration similar to a hydroboration reaction then occurred to give product C, which could be hydrolyzed to afford the final aminoboration product D. We propose that when the substituted substrate 1 e was used, protonation of the C=C bond by the HCl generated in situ led to the formation of a carbenium cation intermediate, which was captured by the phenyl group to yield the Friedel–Crafts alkylation product 3 e.


In summary, we have described the direct intramolecular aminoboration of a variety of N-(4-pentenyl)-, N-(5-hexenyl)-, and N-(2-allylphenyl)sulfonamide substrates by treatment with BCl3. In the presence of BCl3 (1 equiv) as the sole boron source, direct intramolecular aminoboration of these unfunctionalized olefins proceeded readily at room temperature without the use of a catalyst to give the corresponding boronic acids in good yields. The boronic acids could be readily converted into boronates, and the obtained boronates could be further functionalized by oxidation, amination, and Suzuki
coupling reactions. The good yields, mild reaction conditions, and straightforward reaction procedure make this transformation an attractive method for the synthesis of a variety
of useful N-heterocyclic boronic acids and boronates.

Acknowledgements
We acknowledge financial support from the National Natural Science Foundation of China (NSFC 20972072, NSFC 21272121).
 

Organoboron compounds have found widespread application in a variety of carbon–carbon and carbon–heteroatom coupling reactions:

CAS No. 10138-01-9

Nitric acid, europium(3+) salt (3:1)

Catalog No.:AG0004CE MDL No.:MFCD00010993

MF:EuN3O9 MW:337.9787

CAS No. 10138-10-0

Butanoic acid, 4-oxo-, ethyl ester

Catalog No.:AG0004CD MDL No.:MFCD01683413

MF:C6H10O3 MW:130.1418

CAS No. 10138-17-7

1,4-Dioxane, 2,6-dimethyl-

Catalog No.:AG0004CC MDL No.:MFCD01730298

MF:C6H12O2 MW:116.1583

CAS No. 10138-21-3

Silane, dichloroethenylethyl-

Catalog No.:AG0004CB MDL No.:

MF:C4H8Cl2Si MW:155.0978

CAS No. 10138-32-6

Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, ethyl ester

Catalog No.:AG0004CA MDL No.:MFCD00167594

MF:C10H14O2 MW:166.2170

CAS No. 10138-88-2

Phosphine, tris(2,4,4-trimethylpentyl)-

Catalog No.:AG0004D3 MDL No.:

MF:C24H51P MW:370.6355

CAS No. 10138-89-3

Butane, 1,1,3-trimethoxy-

Catalog No.:AG0004D2 MDL No.:

MF:C7H16O3 MW:148.2001

CAS No. 10138-93-9

Ethanamine, N,N-diethyl-, phosphate (1:?)

Catalog No.:AG0004D1 MDL No.:

MF:C6H18NO4P MW:199.1852

CAS No. 10138-94-0

Uranate(2-), bis(acetato-κO)dioxo-, zinc (1:1)

Catalog No.:AG0004D0 MDL No.:

MF:C4H6O6UZn++ MW:453.4957

CAS No. 10138-99-5

L-Alanine, 3-(dimethylamino)-

Catalog No.:AG0004CZ MDL No.:MFCD01695736

MF:C5H12N2O2 MW:132.1610

CAS No. 101382-53-0

3-Quinolinecarboxaldehyde, 1,2-dihydro-6-methyl-2-oxo-

Catalog No.:AG0004CY MDL No.:MFCD02227050

MF:C11H9NO2 MW:187.1947

CAS No. 101382-54-1

3-Quinolinecarboxaldehyde, 1,2-dihydro-8-methyl-2-oxo-

Catalog No.:AG0004CX MDL No.:MFCD02995894

MF:C11H9NO2 MW:187.1947

CAS No. 101382-55-2

3-Quinolinecarboxaldehyde, 1,2-dihydro-7-methoxy-2-oxo-

Catalog No.:AG0004CW MDL No.:MFCD02986395

MF:C11H9NO3 MW:203.1941

CAS No. 101382-56-3

3-Quinolinecarboxaldehyde, 1,2-dihydro-6,7-dimethoxy-2-oxo-

Catalog No.:AG0004CV MDL No.:MFCD07506517

MF:C12H11NO4 MW:233.2200

CAS No. 101382-57-4

2-Propenoic acid, 3-(1,2-dihydro-2-oxo-3-quinolinyl)-

Catalog No.:AG0004CU MDL No.:

MF:C12H9NO3 MW:215.2048

CAS No. 101383-02-2

1,3-Benzenediol, 4-(2-hydroxyethyl)-

Catalog No.:AG0004CT MDL No.:MFCD24445568

MF:C8H10O3 MW:154.1632

CAS No. 101383-04-4

1,3-Benzenediol, 4-(2-hydroxyethyl)-2,6-dimethyl-

Catalog No.:AG0004CS MDL No.:

MF:C10H14O3 MW:182.2164

CAS No. 101383-42-0

1,2-Propanedione, 1-[(6R)-2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]-

Catalog No.:AG0004CR MDL No.:

MF:C9H11N5O3 MW:237.2153

CAS No. 1013835-89-6

1H-Pyrazole-4-carboxaldehyde, 1-(3-methoxyphenyl)-

Catalog No.:AG0004CG MDL No.:MFCD13874001

MF:C11H10N2O2 MW:202.2093

CAS No. 1013835-99-8

1H-Pyrazole-4-carboxaldehyde, 1-(2-methoxyphenyl)-

Catalog No.:AG0004CF MDL No.:MFCD09864239

MF:C11H10N2O2 MW:202.2093

CAS No. 101384-03-6

Ethanone, 1-[4-(1-methyl-1-nitroethyl)-2-furanyl]-

Catalog No.:AG0004CQ MDL No.:

MF:C9H11NO4 MW:197.1879

CAS No. 101384-19-4

Benzene, [(2-chloro-2,3-dimethyl-3-buten-1-yl)thio]-

Catalog No.:AG0004CP MDL No.:

MF:C12H15ClS MW:226.7655

CAS No. 101385-69-7

1H-Imidazolium, 2-chloro-4,5-dihydro-1,3-dimethyl-, hexafluorophosphate(1-) (1:1)

Catalog No.:AG0004CO MDL No.:MFCD00191914

MF:C5H10ClF6N2P MW:278.5635

CAS No. 101385-90-4

3-Pyrrolidinol, 1-(phenylmethyl)-, (3S)-

Catalog No.:AG0004CN MDL No.:MFCD00075485

MF:C11H15NO MW:177.2429

CAS No. 101385-93-7

1-Pyrrolidinecarboxylic acid, 3-oxo-, 1,1-dimethylethyl ester

Catalog No.:AG0004CM MDL No.:MFCD01631194

MF:C9H15NO3 MW:185.2203

CAS No. 101386-00-9

2-Cyclohexen-1-one, 3-hydroxy-2-(2-methyl-1-oxopropyl)-

Catalog No.:AG0004CL MDL No.:

MF:C10H14O3 MW:182.2164

CAS No. 101386-50-9

Ethanone, 2-bromo-1-[4-hydroxy-3-(2-hydroxyethyl)phenyl]-

Catalog No.:AG0004CK MDL No.:

MF:C10H11BrO3 MW:259.0965

CAS No. 101387-48-8

2H-1,3,4-Thiadiazin-5(6H)-one, dihydro-3,4-dimethyl-2-(phenylimino)-

Catalog No.:AG0004CJ MDL No.:

MF:C11H13N3OS MW:235.3054

CAS No. 101387-76-2

Methanone, [4-(4-fluorobenzoyl)-1-piperidinyl](4-nitrophenyl)-

Catalog No.:AG0004CI MDL No.:

MF:C19H17FN2O4 MW:356.3477

CAS No. 101387-98-8

Indeno[5,6-d]imidazol-6(1H)-one, 5,7-dihydro-2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-5,5,7,7-tetramethyl-

Catalog No.:AG0004CH MDL No.:

MF:C22H25N3O3S MW:411.5172

CAS No. 101389-34-8

2H,7H-[1,4]Dioxepino[2,3-g]-1,2,4-benzothiadiazin-3(4H)-one, 8,9-dihydro-2-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-, 1,1-dioxide

Catalog No.:AG0004DH MDL No.:

MF:C23H28N4O6S MW:488.5566

CAS No. 10139-02-3

α-D-Glucopyranoside, 4-nitrophenyl 2-(acetylamino)-2-deoxy-

Catalog No.:AG0004DR MDL No.:MFCD00006592

MF:C14H18N2O8 MW:342.3013

CAS No. 10139-04-5

α-D-Glucopyranoside, phenyl 2-(acetylamino)-2-deoxy-

Catalog No.:AG0004DQ MDL No.:MFCD00067651

MF:C14H19NO6 MW:297.3038

CAS No. 10139-05-6

D-Proline, 1-amino-(9CI)

Catalog No.:AG0004DP MDL No.:

MF:C5H10N2O2 MW:130.1451

CAS No. 10139-25-0

Proline, 1-amino-

Catalog No.:AG0004DO MDL No.:MFCD18071472

MF:C5H10N2O2 MW:130.1451

CAS No. 10139-43-2

1H-Azepine-4-acetic acid, hexahydro-2-oxo-

Catalog No.:AG0004DN MDL No.:

MF:C8H13NO3 MW:171.1937

CAS No. 10139-47-6

Zinc iodide (ZnI2)

Catalog No.:AG0004DM MDL No.:MFCD00011299

MF:I2Zn MW:319.1889

CAS No. 10139-61-4

1(3H)-Isobenzofuranone, 3,3-bis(phenylmethyl)-

Catalog No.:AG0004DK MDL No.:

MF:C22H18O2 MW:314.3771

CAS No. 10139-84-1

Ethanone, 1-(2,4-dihydroxy-3-methylphenyl)-

Catalog No.:AG0004DJ MDL No.:MFCD00010817

MF:C9H10O3 MW:166.1739

CAS No. 10139-98-7

8-Azoniabicyclo[3.2.1]octane, 3-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]-8,8-dimethyl-, bromide, endo- (9CI)

Catalog No.:AG0004DI MDL No.:

MF:C24H30BrNO MW:428.4051

CAS No. 101391-44-0

Bicyclo[1.1.0]butane, 1-bromo-

Catalog No.:AG0004DG MDL No.:

MF:C4H5Br MW:132.9865

CAS No. 1013916-37-4

Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-chloro-8-cyclopentyl-5-methyl-

Catalog No.:AG0004D8 MDL No.:MFCD13181207

MF:C13H14ClN3O MW:263.7228

CAS No. 101392-31-8

3-Pyridinecarboxamide, N-acetyl-1,2-dihydro-2-oxo-

Catalog No.:AG0004DF MDL No.:MFCD24588418

MF:C8H8N2O3 MW:180.1607

CAS No. 101392-86-3

2H-Pyran-2-one, 4-(hydroxymethyl)-3-methyl-

Catalog No.:AG0004DE MDL No.:

MF:C7H8O3 MW:140.1366

CAS No. 1013920-63-2

Carbamic acid, N-[1-(3-pyridinyl)-4-piperidinyl]-, 1,1-dimethylethyl ester

Catalog No.:AG0004D7 MDL No.:MFCD24470614

MF:C15H23N3O2 MW:277.3620

CAS No. 1013921-14-6

Ethanone, 1-[(3S)-3-amino-1-pyrrolidinyl]-

Catalog No.:AG0004D6 MDL No.:MFCD17171257

MF:C6H12N2O MW:128.1723

CAS No. 1013929-55-9

5-ISOXAZOLECARBOXYLIC ACID, 3-AMINO-

Catalog No.:AG0004D5 MDL No.:

MF:C4H4N2O3 MW:128.0862

CAS No. 1013938-10-7

Carbamic acid, N-[1-(aminomethyl)-2-(tetrahydro-2H-pyran-3-yl)ethyl]-, 1,1-dimethylethyl ester

Catalog No.:AG0004D4 MDL No.:

MF:C13H26N2O3 MW:258.3571

CAS No. 101394-13-2

Carbamic acid, (2,3-dichlorophenyl)-, methyl ester (9CI)

Catalog No.:AG0004DD MDL No.:

MF:C8H7Cl2NO2 MW:220.0527

CAS No. 101394-17-6

2,4(1H,3H)-Pyrimidinedione, 1-(2,4-dichlorophenyl)dihydro-3-methyl-

Catalog No.:AG0004DC MDL No.:

MF:C11H10Cl2N2O2 MW:273.1153

CAS No. 101394-18-7

2,4(1H,3H)-Pyrimidinedione, dihydro-3-methyl-1-[4-(trifluoromethyl)phenyl]-

Catalog No.:AG0004DB MDL No.:

MF:C12H11F3N2O2 MW:272.2231

CAS No. 101394-19-8

2,4(1H,3H)-Pyrimidinedione, 3-(2,3-dichlorophenyl)dihydro-1-methyl-

Catalog No.:AG0004DA MDL No.:

MF:C11H10Cl2N2O2 MW:273.1153

CAS No. 101394-21-2

2,4(1H,3H)-Pyrimidinedione, 3-(2,4-dichlorophenyl)dihydro-1-methyl-

Catalog No.:AG0004D9 MDL No.:

MF:C11H10Cl2N2O2 MW:273.1153

CAS No. 101394-27-8

2,4(1H,3H)-Pyrimidinedione, dihydro-1-methyl-3-(1-naphthalenyl)-

Catalog No.:AG0004EG MDL No.:

MF:C15H14N2O2 MW:254.2839

CAS No. 101394-31-4

2-Hexenedioic acid, 2-[(cyclopropylcarbonyl)amino]-, (Z)- (9CI)

Catalog No.:AG0004EF MDL No.:

MF:C10H13NO5 MW:227.2139

CAS No. 101394-53-0

1,4-Butanedione, 1,4-bis(3,4,5-trimethoxyphenyl)-

Catalog No.:AG0004EE MDL No.:

MF:C22H26O8 MW:418.4370

CAS No. 101395-48-6

Benzoic acid, 4-methyl-, 2-oxopropyl ester

Catalog No.:AG0004ED MDL No.:

MF:C11H12O3 MW:192.2112

CAS No. 101395-62-4

Pentanoic acid, 4,4'-(1,2-diazenediyl)bis[4-cyano-2-methyl-

Catalog No.:AG0004EC MDL No.:

MF:C14H20N4O4 MW:308.3330

CAS No. 101395-71-5

1H-Pyrazole-1-ethanamine

Catalog No.:AG0004EB MDL No.:MFCD03727230

MF:C5H9N3 MW:111.1451

CAS No. 101395-72-6

1H-Pyrazole-1-ethanamine, 5-methyl-

Catalog No.:AG0004EA MDL No.:MFCD05053631

MF:C6H11N3 MW:125.1716

CAS No. 101396-13-8

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,3-bis(1-methylethyl) ester

Catalog No.:AG0004E9 MDL No.:

MF:C12H19O7- MW:275.2751

CAS No. 101396-14-9

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(1-methylethyl) ester

Catalog No.:AG0004E8 MDL No.:

MF:C12H19O7- MW:275.2751

CAS No. 101396-15-0

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1-(1-methylethyl) ester

Catalog No.:AG0004E7 MDL No.:

MF:C9H12O7-- MW:232.1874

CAS No. 101396-91-2

1-Propanaminium, 3-chloro-2-hydroxy-N,N,N-trimethyl-, chloride (1:1), (2S)-

Catalog No.:AG0004E6 MDL No.:

MF: MW:

CAS No. 101397-00-6

2-Propenamide, 2-cyano-3-[5-(dimethylamino)-2-furanyl]-, (E)- (9CI)

Catalog No.:AG0004E5 MDL No.:

MF:C10H11N3O2 MW:205.2132

CAS No. 101397-51-7

1,3,2-Benzodioxaphosphol-2-amine, N-(4-chlorophenyl)-, 2-sulfide

Catalog No.:AG0004E4 MDL No.:

MF:C12H9ClNO2PS MW:297.6971

CAS No. 101397-75-5

1,3-Dioxa-2-silacycloheptane, 2,2,4,4,7,7-hexamethyl-

Catalog No.:AG0004E3 MDL No.:

MF:C10H22O2Si MW:202.3660

CAS No. 101398-16-7

Acetamide, N-[2-[(2-benzoyl-4-chlorophenyl)amino]-2-oxoethyl]-2-chloro-

Catalog No.:AG0004E2 MDL No.:

MF:C17H14Cl2N2O3 MW:365.2107

CAS No. 101398-19-0

3-Furanol, tetrahydro-2,2-dimethyl-

Catalog No.:AG0004E1 MDL No.:

MF:C6H12O2 MW:116.1583

CAS No. 101398-30-5

Propanedinitrile, 2-[2-(2-bromophenyl)hydrazinylidene]-

Catalog No.:AG0004E0 MDL No.:

MF:C9H5BrN4 MW:249.0668

CAS No. 101398-31-6

Propanedinitrile, 2-[2-[2-(trifluoromethyl)phenyl]hydrazinylidene]-

Catalog No.:AG0004DZ MDL No.:MFCD00042196

MF:C10H5F3N4 MW:238.1687

CAS No. 101398-32-7

Propanedinitrile, 2-[2-(2-hydroxyphenyl)hydrazinylidene]-

Catalog No.:AG0004DY MDL No.:

MF:C9H6N4O MW:186.1701

CAS No. 101398-33-8

Propanedinitrile, 2-[2-(2,5-dimethylphenyl)hydrazinylidene]-

Catalog No.:AG0004DX MDL No.:

MF:C11H10N4 MW:198.2239

CAS No. 101398-40-7

Formamide, N-methyl-N-(2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-9-yl)-

Catalog No.:AG0004DW MDL No.:

MF:C14H18N2O MW:230.3055

CAS No. 101398-43-0

Methanimidamide, N'-9-acridinyl-N,N-dimethyl-, compd. with iodomethane (1:1)

Catalog No.:AG0004DV MDL No.:

MF:C17H18IN3 MW:391.2494

CAS No. 101398-65-6

Methanimidamide, N'-(2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-

Catalog No.:AG0004DU MDL No.:

MF:C12H16N2 MW:188.2688

CAS No. 101399-39-7

Phenylalanine, N-(4-aminobenzoyl)-

Catalog No.:AG0004DT MDL No.:

MF:C16H16N2O3 MW:284.3098

CAS No. 101399-43-3

Alanine, benzyl ester, benzenesulfonate (6CI)

Catalog No.:AG0004DS MDL No.:

MF:C16H19NO5S MW:337.3908

CAS No. 1014-05-7

Piperazine, 1-(3,4-dimethylphenyl)-

Catalog No.:AG0004F3 MDL No.:MFCD00023129

MF:C12H18N2 MW:190.2847

CAS No. 1014-18-2

Ethanone, 2-bromo-1-(2,3-dihydro-1,4-benzodioxin-2-yl)-

Catalog No.:AG0004F2 MDL No.:MFCD04972619

MF:C10H9BrO3 MW:257.0807

CAS No. 1014-23-9

Oxazole, 5-(4-nitrophenyl)-

Catalog No.:AG0004F1 MDL No.:MFCD00085148

MF:C9H6N2O3 MW:190.1555

CAS No. 1014-25-1

1,3,4-Thiadiazol-2-amine, 5-(4-methoxyphenyl)-

Catalog No.:AG0004F0 MDL No.:MFCD00813220

MF:C9H9N3OS MW:207.2523

CAS No. 1014-60-4

Benzene, 1,3-bis(1,1-dimethylethyl)-

Catalog No.:AG0004EZ MDL No.:MFCD00008830

MF:C14H22 MW:190.3245

CAS No. 1014-66-0

Benzene, 1-nitro-4-[(trimethylsilyl)oxy]-

Catalog No.:AG0004EY MDL No.:

MF:C9H13NO3Si MW:211.2899

CAS No. 1014-77-3

3-Pyridazinamine, 6-chloro-N-cyclohexyl-

Catalog No.:AG0004EX MDL No.:MFCD00968568

MF:C10H14ClN3 MW:211.6913

CAS No. 1014-81-9

Benzoic acid, 3-(trifluoromethoxy)-

Catalog No.:AG0004EW MDL No.:MFCD00041501

MF:C8H5F3O3 MW:206.1187

CAS No. 1014-93-3

Benzene, [[(5-bromopentyl)oxy]methyl]-

Catalog No.:AG0004EV MDL No.:MFCD02258456

MF:C12H17BrO MW:257.1668

CAS No. 1014-94-4

Carbonothioic acid, O-methyl O-(4-nitrophenyl) ester

Catalog No.:AG0004EU MDL No.:

MF:C8H7NO4S MW:213.2105

CAS No. 1014-99-9

Benzene, 1,4-bis(isothiocyanatomethyl)-

Catalog No.:AG0004ET MDL No.:

MF:C10H8N2S2 MW:220.3139

CAS No. 10140-30-4

4-Octadecene-1,3-diol, 2-amino-

Catalog No.:AG0004ES MDL No.:

MF:C18H37NO2 MW:299.4919

CAS No. 10140-70-2

2H-3-Benzoxacyclododecin-2,10(1H)-dione, 4,5,6,7,8,9-hexahydro-11,13-dihydroxy-4-methyl-, (4S)-

Catalog No.:AG0004ER MDL No.:

MF:C16H20O5 MW:292.3270

CAS No. 10140-87-1

Ethanol, 1,2-dichloro-, 1-acetate

Catalog No.:AG0004EQ MDL No.:

MF:C4H6Cl2O2 MW:156.9952

CAS No. 10140-89-3

Propanal, 2,3-dichloro-

Catalog No.:AG0004EP MDL No.:

MF:C3H4Cl2O MW:126.9693

CAS No. 10140-96-2

Hexanoic acid, 6-chloro-, ethyl ester

Catalog No.:AG0004EO MDL No.:MFCD01723370

MF:C8H15ClO2 MW:178.6565

CAS No. 101400-59-3

2-Propenenitrile, 3-(2,2,3-trimethyl-6-methylenecyclohexyl)-

Catalog No.:AG0004EN MDL No.:

MF:C13H19N MW:189.2967

CAS No. 101401-80-3

Benzamide, 4-nitro-N-[(1S)-1-phenylethyl]-

Catalog No.:AG0004EM MDL No.:

MF:C15H14N2O3 MW:270.2833

CAS No. 101401-81-4

Benzamide, 4-nitro-N-[(1R)-1-phenylethyl]-

Catalog No.:AG0004EL MDL No.:

MF:C15H14N2O3 MW:270.2833

CAS No. 101401-88-1

4a,7-Epoxy-3,8b-ethano-1H,5aH-cyclopenta[4,5]furo[3,2-c]pyran-5a-methanol, hexahydro-3,8a-dimethyl-, (3S,4aR,5aR,7R,8aR,8bR)- (9CI)

Catalog No.:AG0004EK MDL No.:

MF:C15H22O4 MW:266.3328

CAS No. 101401-98-3

5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-8-hydroxy-

Catalog No.:AG0004EJ MDL No.:

MF:C20H16O4 MW:320.3386

CAS No. 101402-20-4

Ethanimidamide, N'-phenyl-N-[(trimethylsilyl)methyl]-

Catalog No.:AG0004EI MDL No.:

MF:C12H20N2Si MW:220.3861

CAS No. 101402-29-3

Benzenecarbothioamide, N-[(trimethylsilyl)methyl]-

Catalog No.:AG0004EH MDL No.:

MF:C11H17NSSi MW:223.4099

CAS No. 101402-44-2

2H-Pyrrole-4-carboxylic acid, 3,4-dihydro-5-phenyl-, methyl ester

Catalog No.:AG0004FJ MDL No.:

MF:C12H13NO2 MW:203.2371

CAS No. 101402-58-8

5,8-Quinolinedione, 2-chloro-4-methyl-

Catalog No.:AG0004FI MDL No.:

MF:C10H6ClNO2 MW:207.6131

CAS No. 101403-24-1

2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-N-propyl-, (2S)-

Catalog No.:AG0004FH MDL No.:

MF:C14H21NO MW:219.3226

CAS No. 101403-71-8

Benzene, 5-(diethoxymethyl)-1,2,3-trimethoxy-

Catalog No.:AG0004FG MDL No.:

MF:C14H22O5 MW:270.3215

CAS No. 10141-00-1

Sulfuric acid, chromium(3+) potassium salt (2:1:1)

Catalog No.:AG0004FR MDL No.:MFCD00011363

MF:CrKO8S2 MW:283.2196

CAS No. 10141-44-3

Benzofuran, 6-methoxy-2-(2,3,4-trimethoxyphenyl)-

Catalog No.:AG0004FP MDL No.:

MF:C18H18O5 MW:314.3325

CAS No. 10141-46-5

Urea, N-(4-aminophenyl)-N'-phenyl-

Catalog No.:AG0004FO MDL No.:MFCD01593571

MF:C13H13N3O MW:227.2618

CAS No. 10141-50-1

Benzenamine, 4-ethoxy-, sulfate (1:1)

Catalog No.:AG0004FN MDL No.:

MF:C8H13NO5S MW:235.2575

CAS No. 10141-51-2

Benzenamine, 4-(3-methylbutoxy)-, hydrochloride (9CI)

Catalog No.:AG0004FM MDL No.:

MF:C11H18ClNO MW:215.7197

CAS No. 10141-52-3

Benzenamine, 4-(2-methoxyethoxy)-, hydrochloride (1:1)

Catalog No.:AG0004FL MDL No.:MFCD09431468

MF:C9H14ClNO2 MW:203.6660

CAS No. 10141-65-8

Uridine, 5,6-dihydro-6-hydroxy- (9CI)

Catalog No.:AG0004FK MDL No.:

MF:C9H14N2O7 MW:262.2167

CAS No. 101410-18-8

1-Pyrrolidinecarboxylic acid, 2-(aminothioxomethyl)-, 1,1-dimethylethyl ester, (2S)-

Catalog No.:AG0004FF MDL No.:MFCD06738835

MF:C10H18N2O2S MW:230.3271

CAS No. 101411-53-4

3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2-[(2-hydroxyethoxy)methyl]-6-methyl-, 3-ethyl 5-methyl ester

Catalog No.:AG0004FE MDL No.:

MF:C20H23Cl2NO6 MW:444.3057

CAS No. 101412-74-2

Lithium, (9-phenoxy-9H-fluoren-9-yl)-

Catalog No.:AG0004FD MDL No.:

MF:C19H13LiO MW:264.2469

CAS No. 101413-49-4

1-Propanamine, 2-methyl-N-(2-methylpropyl)-, acetate (1:1)

Catalog No.:AG0004FC MDL No.:

MF:C10H23NO2 MW:189.2951

CAS No. 101414-10-2

Benzene, 1,1'-(2-chloro-1-propen-1-ylidene)bis[4-chloro-

Catalog No.:AG0004FB MDL No.:

MF:C15H11Cl3 MW:297.6068

CAS No. 101414-54-4

Benzenecarboximidic acid, N-[(4-nitrophenyl)thio]-, ethyl ester (9CI)

Catalog No.:AG0004FA MDL No.:

MF:C15H14N2O3S MW:302.3483

CAS No. 101414-55-5

Benzenecarboximidic acid, N-[(4-nitrophenyl)thio]-, methyl ester (9CI)

Catalog No.:AG0004F9 MDL No.:

MF:C14H12N2O3S MW:288.3217

CAS No. 101415-87-6

2,4-Heptadienal, 6,6-dimethyl-, (2E,4E)-

Catalog No.:AG0004F8 MDL No.:

MF:C9H14O MW:138.2069

CAS No. 101417-05-4

Oxirane, 2,2'-[(1-decyl-1,2-ethanediyl)bis(oxymethylene)]bis-

Catalog No.:AG0004F7 MDL No.:

MF:C18H34O4 MW:314.4602

CAS No. 101417-40-7

1,3-Benzodioxole, 4-(bromomethyl)-

Catalog No.:AG0004F6 MDL No.:MFCD21604251

MF:C8H7BrO2 MW:215.0440

CAS No. 101417-68-9

2,4,6-Octatrienedial, (2E,4E,6E)-

Catalog No.:AG0004F5 MDL No.:

MF:C8H8O2 MW:136.1479

© 2019 Angene International Limited. All rights Reserved.